EVIDENCE LIBRARY
Cerebral Malaria Seizure Trial: Benzodiazepine Rescue Changed the Comparator Pathway
A small pediatric trial changed when phenobarbital was given, making its efficacy comparison conditional on the revised treatment sequence.
A small pediatric trial changed when phenobarbital was given, making its efficacy comparison conditional on the revised treatment sequence.
The protocol changed during the study
Children with cerebral malaria received enteral levetiracetam or a phenobarbital pathway. Safety concerns led to phenobarbital being reserved for continuing seizures after benzodiazepines. Consequently, only 15 of 21 assigned children received phenobarbital. The study found no significant difference in several seizure and clinical outcomes, with respiratory problems prompting phenobarbital discontinuation in three recipients.
Assignment was not identical to exposure
The authors acknowledged that withholding phenobarbital until further seizures could affect the comparison. The findings therefore do not establish equivalence to universal phenobarbital administration or isolate the efficacy of benzodiazepine rescue. Small samples, open-label care, and the specialized illness setting matter. The paper illustrates why treatment sequence and actual administration must accompany a randomized assignment label when interpreting results.
Source paper
Original analysis of the supplied journal article, identified as PMC6824014.